methanearsonous acid has been researched along with verlukast in 1 studies
| Studies (methanearsonous acid) | Trials (methanearsonous acid) | Recent Studies (post-2010) (methanearsonous acid) | Studies (verlukast) | Trials (verlukast) | Recent Studies (post-2010) (verlukast) |
|---|---|---|---|---|---|
| 101 | 0 | 48 | 396 | 14 | 115 |
| Protein | Taxonomy | methanearsonous acid (IC50) | verlukast (IC50) |
|---|---|---|---|
| Multidrug resistance-associated protein 1 | Homo sapiens (human) | 2.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carew, MW; Hao, WH; Le, XC; Loo, JF; Naranmandura, H; Xu, S; Zhang, YF | 1 |
1 other study(ies) available for methanearsonous acid and verlukast
| Article | Year |
|---|---|
Multidrug resistance protein 1 (ABCC1) confers resistance to arsenic compounds in human myeloid leukemic HL-60 cells.
Topics: Antineoplastic Agents; Apoptosis; Arsenites; Biotransformation; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; HL-60 Cells; Humans; Inhibitory Concentration 50; Leukemia, Promyelocytic, Acute; Multidrug Resistance-Associated Proteins; Organometallic Compounds; Propionates; Quinolines; Sodium Compounds | 2013 |